NASDAQ · Financial Statements

Impel Pharmaceuticals Inc. (IMPL) Financial Statements

$0.04 NASDAQ: IMPL Market Cap $956000

Impel Pharmaceuticals Inc. most recently reported annual revenue of $13.0M, net profit of $-129.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric2019202020212022
Revenue$0$0$1.0M$13.0M
Operating Profit$-42.0M$-45.0M$-71.0M$-83.0M
Net Profit$-42.0M$-46.0M$-77.0M$-129.0M
EPS$-3.19$-3.49$-5.24$-5.52
Op Margin——-10701.5%-657.5%

Balance Sheet (USD)

Metric2019202020212022
Total Assets$42.0M$12.0M$98.0M$89.0M
Total Liabilities$134.0M$146.0M$45.0M$133.0M
Cash$37.0M$7.0M$88.0M$61.0M
Borrowings$0$8.0M$29.0M$51.0M

Cash Flow (USD)

Metric2019202020212022
Operating Cash Flow$-36.0M$-39.0M$-66.0M$-94.0M
Investing Cash Flow$-3.0M$-4.0M$-1.0M$-3.0M
Financing Cash Flow$0$11.0M$148.0M$67.0M
Net Cash Flow$-38.0M$-30.0M$81.0M$-28.0M
Free Cash Flow$-38.0M$-41.0M$-67.0M$-95.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA0.09
FCF Yield-9939.23%
Quick Ratio3.22
Interest Coverage-6.01
Return 1Y—
Return 3Y—
Return 5Y—

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
IMPL Overview IMPL Dividend Run Stock Screener